help button home button Am J Pathol sign up for etoc
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, S. K.
Right arrow Articles by Heptinstall, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, S. K.
Right arrow Articles by Heptinstall, R. H.

American Journal of Pathology, Vol 102, 62-71, Copyright © 1981 by American Society for Investigative Pathology

REGULAR ARTICLES

The effects of heparin treatment on hypertension and vascular lesions in stroke-prone spontaneously hypertensive rats

SK Wilson, K Solez, JK Boitnott and RH Heptinstall

Stroke-prone spontaneously hypertensive rats (SPSHRs) were used to test the theory that heparin treatment may prevent the development of "malignant" hypertension and fibrinoid vascular lesions in the kidney. Subcutaneous injections of heparin (100 units/100 g body weight) were given every 8 hours over a 5-week period to 12 young (10-week-old) SPSHRs. A control group of 12 SPSHRs was injected with saline. Both heparin-treated and control animals showed an incremental rise in mean systolic pressure, but the pressure was significantly lower (P less than 0.05) in the heparin-treated animals during weeks 1-4 of treatment. There were significantly fewer fibrinoid vascular lesions (P less than 0.03) in the heparin-treated group. In 7 additional heparin- treated and 7 control SPSHRs plasma and blood volumes were determined for assessment of the effects of heparin treatment. There was no significant difference in total blood volume or plasma volume between the two groups, but heparin-treated animals had lower hematocrit levels. In 8 SPSHRs direct arterial pressures were recorded for 1 hour after a single heparin injection, and no acute changes in blood pressure were observed. The results suggest that heparin treatment prevents the development of severe fibrinoid vascular lesions and also attenuates the rate of the rise in systolic blood pressure; moreover, this reduction in blood pressure is not caused by a significant reduction in blood volume or an acute hypotensive effect of heparin.


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
S. Benchetrit, A. Mandelbaum, J. Bernheim, E. Podjarny, J. Green, B. Katz, and M. Rathaus
Altered vascular reactivity following partial nephrectomy in the rat: a possible mechanism of the blood-pressure-lowering effect of heparin
Nephrol. Dial. Transplant., January 1, 1999; 14(1): 64 - 69.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
R. J. Dilley and M. I. Nataatmadja
Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats
Cardiovasc Res, April 1, 1998; 38(1): 247 - 255.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Society for Investigative Pathology.